We know it's tough to keep track of all the different maternal and children's health foundations, coalitions, and initiatives, with tons out there and more cropping up every day. Each large scale partnership or initiative fills a niche, seeking to reduce maternal mortality through slightly different means. Maternova has put together a cheat-sheet on these newer campaigns and initiatives.
Identification of anemia in pregnant women is important, since it is an important cause of multiple complications during pregnancy (preterm delivery, low birth weight and perinatal death), so it is recommended to all pregnant women, in the first prenatal visit and at 28 weeks of gestation, the measurement of serum concentrations of hemoglobin and hematocrit as a screening test for anemia.
Prenatal assessment seeks to identify, through clinical history, sociodemographic characteristics, mean blood pressure, Doppler of the uterine arteries and biochemical markers such as pregnancy-associated plasma protein A (PAPP-A) and placental growth factor (PlGF), those women who are at high risk of developing preeclampsia in order to take appropriate measures. that can help reduce that risk.